肝癌的免疫治疗

被引：6

作者：

张其顺

机构：

[1] 广西医科大学第四附属医院肝胆外科

来源：

齐齐哈尔医学院学报 | 2010年 / 31卷 / 03期

关键词：

肝癌; 非特异性免疫治疗; 主动免疫治疗; 过继免疫治疗; 树突状细胞; 细胞因子;

D O I：

暂无

中图分类号：

R735.7 [肝肿瘤];

学科分类号：

100112 [医学生物化学与分子生物学];

摘要：

肝癌的治疗迫切需要新的治疗方法 ,免疫治疗是近年来兴起的最有前景的新疗法,其吸引人之处在于能激发特异性免疫反应,通过不同途径识别和攻击肿瘤细胞,从而控制或杀灭肿瘤细胞。肝癌的免疫治疗主要包括非特异性免疫治疗、主动免疫治疗和过继免疫治疗三大部分。本文就细胞因子、免疫佐剂、树突状细胞(DC)疫苗、自体肿瘤细胞疫苗、效应细胞过继治疗等治疗策略在肝癌的动物和临床实验中的一些进展做一概述。

引用

页码：420 / 423

页数：4

共 13 条

[1]

Endolymphatic immunotherapy in inoperable hepatocellular carcinoma [J].

Bertelli, R. ;

Neri, F. ;

Tsivian, M. ;

Ruhrman, N. ;

Cavallari, G. ;

Beltempo, P. ;

Puviani, L. ;

DeVinci, C. ;

Pizza, G. ;

Nardo, B. .

TRANSPLANTATION PROCEEDINGS, 2008, 40 (06) :1913-1915

[2]

Tumor recurrence after partial hepatectomy for liver metastases in rats:: Prevention by in vivo injection of irradiated cancer cells expressing GMCSF and IL-12 [J].

Aussilhou, Breatrice ;

Panis, Yves ;

Alves, Arnaud ;

Nicco, Carole ;

Klatzmann, David .

JOURNAL OF SURGICAL RESEARCH, 2008, 149 (02) :184-191

[3]

Immunotherapy of hepatocellular carcinoma with a vaccine based on xenogeneic homologous α fetoprotein in mice [J].

Zhang, Wei ;

Liu, Jiyan ;

Wu, Yang ;

Xiao, Fei ;

Wang, Younsheng ;

Wang, Rui ;

Yang, Hanshuo ;

Wang, Guoqing ;

Yang, Jinliang ;

Deng, Hongxin ;

Li, Jiong ;

Wen, Yanjun ;

Wei, Yuquan .

BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2008, 376 (01) :10-14

[4]

Efficiency of adjuvant active specific immunization with Newcastle disease virus modified tumor cells in colorectal cancer patients following resection of liver metastases: results of a prospective randomized trial [J].

Schulze, T. ;

Kemmner, W. ;

Weitz, J. ;

Wernecke, K. -D. ;

Schirrmacher, V. ;

Schlag, P. M. .

CANCER IMMUNOLOGY IMMUNOTHERAPY, 2009, 58 (01) :61-69

[5]

Adjuvant treatments for resectable hepatocellular carcinoma [J].

Ishii, Hiroshi ;

Yamamoto, Junji ;

Ikari, Takaaki .

JOURNAL OF HEPATO-BILIARY-PANCREATIC SURGERY, 2008, 15 (05) :459-462

[6]

Anti-tumor activity of ex vivo expanded cytokine-induced killer cells against human hepatocellular carcinoma [J].

Kim, Hwan Mook ;

Lim, Jaeseung ;

Yoon, Yeo Dae ;

Ahn, Ji Mi ;

Kang, Jong Soon ;

Lee, Kiho ;

Park, Song-Kyu ;

Jeong, Yu Jin ;

Kim, Jin Mi ;

Han, Gyoonhee ;

Yang, Kyu-Hwan ;

Kim, Yeon Jin ;

Kim, Youngsoo ;

Han, Sang-Bae .

INTERNATIONAL IMMUNOPHARMACOLOGY, 2007, 7 (13) :1793-1801

[7]

A randomized, controlled trial of postoperative adjuvant interferon therapy after resection of hepatocellular carcinoma [J].

Lo, Chung Mau ;

Liu, Chi Leung ;

Chan, See Ching ;

Lam, Chi Ming ;

Poon, Ronnie T. P. ;

Ng, Irene O. L. ;

Fan, Sheung Tat ;

Wong, John .

ANNALS OF SURGERY, 2007, 245 (06) :831-842

[8]

Mechanism of antitumor effect on mouse hepatocellular carcinoma by intratumoral injection of OK-432, a streptococcal preparation [J].

Homma, Sadamu ;

Sagawa, Yukiko ;

Komita, Hideo ;

Koido, Shigeo ;

Nagasaki, Eijiro ;

Ryoma, Yoshiki ;

Okamoto, Masato .

CANCER IMMUNOLOGY IMMUNOTHERAPY, 2007, 56 (08) :1265-1274

[9]

Postoperative interferon α treatment postponed recurrence and improved overall survival in patients after curative resection of HBV-related hepatocellular carcinoma:: a randomized clinical trial [J].

Sun, Hui-Chuan ;

Tang, Zhao-You ;

Wang, Lu ;

Qin, Lun-Xiu ;

Ma, Zeng-Chen ;

Ye, Qin-Hai ;

Zhang, Bo-Heng ;

Qian, Yong-Bin ;

Wu, Zhi-Quan ;

Fan, Jia ;

Zhou, Xin-Da ;

Zhou, Jian ;

Qiu, Shuang-Jian ;

Shen, Yue-Fang .

JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2006, 132 (07) :458-465

[10]

The effect of menatetrenone; a vitamin K2 analog; on disease recurrence and survival in patients with hepatocellular carcinoma after curative treatment.[J].Toshihiko Mizuta M.D.;Iwata Ozaki M.D.;Yuichiro Eguchi M.D.;Tsutomu Yasutake M.D.;Seiji Kawazoe M.D.;Kazuma Fujimoto M.D.;Kyosuke Yamamoto M.D..Cancer.2006, 4

← 1 2 →